Pharmacokinetics

Ophthalmology

Volumn 116, Issue 1, 2009, Pages 168-169

  Byeon, Suk Ho ^a   Kang, Sung Yong ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; DRUG BLOOD LEVEL; DRUG CLEARANCE; LETTER; NONHUMAN; PRIORITY JOURNAL; VITREOUS BODY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; HALF-LIFE; MODELS, BIOLOGICAL; RABBITS; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 57949095389     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.09.016     Document Type: Letter

References (7)

1. Bakri S.J., Snyder M.R., Reid J.M., et al. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology 114 (2007) 2179-2182
2. Bakri S.J., Snyder M.R., Reid J.M., et al. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114 (2007) 855-859
3. Kim H., Csaky K.G., Chan C.C., et al. The pharmacokinetics of rituximab following an intravitreal injection. Exp Eye Res 82 (2006) 760-766
4. Leon S., and Yu A. Applied Biopharmaceutics and Pharmacokinetics (1999), McGraw-Hill/Appleton & Lange, New York 607-666
5. Gaudreault J., Fei D., Beyer J.C., et al. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits. Retina 27 (2007) 1260-1266
6. Gaul G.R., and Brubaker R.F. Measurement of aqueous flow in rabbits with corneal and vitreous depots of fluorescent dye. Invest Ophthalmol Vis Sci 27 (1986) 1331-1335
7. Malhotra B.K., Brundage R.C., Lemaire M., and Sawchuk R.J. Modeling the route of administration-based enhancement in the brain delivery of EAB 515, studied by microdialysis. J Drug Target 4 (1997) 277-288